Given that anti-MDA5 positive DM patients tend to develop ILD with a poor prognosis, this may be responsible for the increased proportion of Th1-related cytokines and IL18R1+ CD4+ cells in the peripheral blood of patients. The gene discussed is IFIH1; the disease is dermatomyositis.